Pfizer Inc. expects to roughly quadruple the price of its COVID-19 vaccine in the US to about $110 to $130 per dose after the United States government’s current purchase program expires, Pfizer executive Angela Lukin said on Thursday.
PHILIPPINE STAR/ MICHAEL VARCAS
Ms. Lukin said she expects the vaccine — currently provided for free to all by the government — will be made available at no cost to people who have private insurance or government paid insurance. The US government currently pays around $30 per dose to Pfizer and German partner BioNTech SE. In 2023, the market is expected to move to private insurance after the US public health emergency expires.
So far the US rollout of updated COVID-19 booster shots which target both the original coronavirus strain and the Omicron strain has lagged last year’s rate despite more people being eligible for the shots.